A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...
Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive disease-modifying drugs, a new study has found. Uncertainty about the impact of these drugs during pregnancy ...
Hosted on MSN
Multiple sclerosis medication gap: Study finds women less likely than men to receive drugs
Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use ...
—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...
MINNEAPOLIS — Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women’s childbearing years, even when those drugs have been shown to be ...
Living with multiple sclerosis (MS) often means managing a mix of symptoms that affect daily life, including fatigue, mobility challenges, pain, and changes in strength and endurance. Body weight can ...
Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis. The first speaker, Darla ...
Christina Applegate says multiple sclerosis (MS) pain limits movement and keeps her largely bedridden, highlighting the disabling impact of the neurological disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results